TNFα cleavage beyond TACE/ADAM17: Matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis

EMBO Molecular Medicine

Volumn 5, Issue 7, 2013, Pages 970-972

  Becker Pauly, Christoph ^a   Rose John, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

ADAM protease; Inflammatory bowel disease; MMP13; Protease web; Sepsis

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COLLAGENASE 3; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRILYSIN; MYELOBLASTIN; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ARTICLE; BIOLOGICAL ACTIVITY; COLITIS; ENDOCYTOSIS; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MASS SPECTROMETRY; MICROENVIRONMENT; NERVE DEGENERATION; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; SEPSIS; SEPTIC SHOCK; SHORT COURSE THERAPY;

EID: 84880017266     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201302899     Document Type: Article

References (10)

1. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M (2012) Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335: 225-228
2. Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, et al (2011) Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365: 1502-1508
3. Chalaris A, Adam N, Sina C, Rosenstiel P, Lehmann-Koch J, Schirmacher P, Hartmann D, Cichy J, Gavrilova O, Schreiber S, et al (2010) Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med 207: 1617-1624
4. Dufour A, Overall CM (2013) Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 34: 233-242
5. Horiuchi K, Kimura T, Miyamoto T, Takaishi H, Okada Y, Toyama Y, Blobel CP (2007) Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 179: 2686-2689
6. Le Gall SM, Bobe P, Reiss K, Horiuchi K, Niu XD, Lundell D, Gibb DR, Conrad D, Saftig P, Blobel CP (2009) ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, l-selectin, and tumor necrosis factor alpha. Mol Biol Cell 20: 1785-1794
7. Robache-Gallea S, Morand V, Bruneau JM, Schoot B, Tagat E, Realo E, Chouaib S, Roman-Roman S (1995) In vitro processing of human tumor necrosis factor-alpha. J Biol Chem 270: 23688-23692
8. Scheller J, Chalaris A, Garbers C, Rose-John S (2011) ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 32: 380-387
9. Vandenbroucke RE, Dejonckheere E, Van Hauwermeiren F, Lodens S, De Rycke R, Van Wonterghem E, Staes A, Gevaert K, Lopez-Otin C, Libert C (2013) Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. EMBO Mol Med 5: 932-948
10. Yanez-Mo M, Gutierrez-Lopez MD, Cabanas C (2011) Functional interplay between tetraspanins and proteases. Cell Mol Life Sci 68: 3323-3335